CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Key Financials
Gross Profit
$3806
↓ 42.3%
Net Income
$-5995008
↓ 9.1%
Revenue
$6000
↓ 45.5%
Total Assets
$7.8M
↑ 17.1%
Total Liabilities
$284880.00
↓ 13.1%
EPS (Diluted)
$-2.52
↑ 32.1%
Shareholders' Equity
$7.5M
↑ 18.5%
Cash & Equivalents
$10.7M
↑ 10841.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/8/2026 | View on SEC |
| 10-K/A | 4/24/2026 | View on SEC |
| 10-K | 3/20/2026 | View on SEC |
| 8-K | 12/31/2025 | View on SEC |
| 8-K | 12/19/2025 | View on SEC |
| 424B3 | 12/16/2025 | View on SEC |
| EFFECT | 12/12/2025 | View on SEC |
| CORRESP | 12/9/2025 | View on SEC |
| S-3 | 11/21/2025 | View on SEC |
| DEF 14A | 11/13/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CELZ |
| Company Name | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. |
| CIK | 1187953 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 480-399-2822 |